Tiziana Life Sciences to Present at BIO-Europe 2025
Ticker: TLSA · Form: 6-K · Filed: Oct 29, 2025 · CIK: 1723069
Sentiment: neutral
Topics: conference-participation, life-sciences, partnership
TL;DR
Tiziana Life Sciences is presenting at BIO-Europe 2025 (Nov 3-5) to find partners.
AI Summary
Tiziana Life Sciences Ltd announced on October 29, 2025, its participation as a presenting company at BIO-Europe 2025. This premier life sciences partnering conference is scheduled to take place from November 3-5, 2025, in Vienna.
Why It Matters
Participation in BIO-Europe 2025 provides Tiziana Life Sciences with a platform to showcase its advancements and potentially secure partnerships within the life sciences industry.
Risk Assessment
Risk Level: low — This filing is a routine announcement of participation in a conference, with no immediate financial or operational impact disclosed.
Key Players & Entities
- Tiziana Life Sciences LTD (company) — Registrant
- BIO-Europe 2025 (event) — Conference where Tiziana will present
- November 3-5, 2025 (date) — Dates of BIO-Europe 2025
- October 29, 2025 (date) — Date of the 6-K filing
FAQ
What is the purpose of Tiziana Life Sciences' participation in BIO-Europe 2025?
The purpose is to present the company at Europe's premier life sciences partnering conference, likely to explore partnerships and showcase advancements.
When and where will BIO-Europe 2025 take place?
BIO-Europe 2025 will take place from November 3-5, 2025, at the Vienna Exhibition and Congress.
What type of company is Tiziana Life Sciences LTD?
Tiziana Life Sciences LTD is a foreign private issuer in the pharmaceutical preparations industry.
What form is this SEC filing?
This SEC filing is a Form 6-K, which is a Report of Foreign Private Issuer.
What is the principal executive office address for Tiziana Life Sciences LTD?
The principal executive office address is 9th Floor, 107 Cheapside, London EC2V 6DN.
Filing Stats: 321 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2025-10-29 07:00:38
Filing Documents
- ea0262929-6k_tiziana.htm (6-K) — 15KB
- ea026292901ex99-1_tiziana.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 12KB
- 0001213900-25-103246.txt ( ) — 42KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TIZIANA LIFE SCIENCES LTD Date: October 29, 2025 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 2 EXHIBIT INDEX Exhibit No. Description 99.1 Tiziana Life Sciences LTD Press Release, dated October 29, 2025 3